Heinonen OP - Search Results

1

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Frick MH, et al. Among authors: heinonen op. N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001. N Engl J Med. 1987. PMID: 3313041 Clinical Trial.

2

Serum ferritin and ceruloplasmin as coronary risk factors.

Mänttäri M, Manninen V, Huttunen JK, Palosuo T, Ehnholm C, Heinonen OP, Frick MH. Mänttäri M, et al. Among authors: heinonen op. Eur Heart J. 1994 Dec;15(12):1599-603. doi: 10.1093/oxfordjournals.eurheartj.a060440. Eur Heart J. 1994. PMID: 7698127

3

The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.

Huttunen JK, Heinonen OP, Manninen V, Koskinen P, Hakulinen T, Teppo L, Mänttäri M, Frick MH. Huttunen JK, et al. Among authors: heinonen op. J Intern Med. 1994 Jan;235(1):31-9. doi: 10.1111/j.1365-2796.1994.tb01029.x. J Intern Med. 1994. PMID: 8283157 Clinical Trial.

4

The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up.

Heinonen OP, Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Tenkanen L, Frick MH. Heinonen OP, et al. J Intern Med. 1994 Jan;235(1):41-9. doi: 10.1111/j.1365-2796.1994.tb01030.x. J Intern Med. 1994. PMID: 8283158 Clinical Trial.

5

Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.

Frick MH, Heinonen OP, Huttunen JK, Koskinen P, Mänttäri M, Manninen V. Frick MH, et al. Among authors: heinonen op. Ann Med. 1993 Feb;25(1):41-5. doi: 10.3109/07853899309147855. Ann Med. 1993. PMID: 8435186 Clinical Trial.

6

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.

Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Rapola JM, et al. Among authors: heinonen op. Lancet. 1997 Jun 14;349(9067):1715-20. doi: 10.1016/S0140-6736(97)01234-8. Lancet. 1997. PMID: 9193380 Clinical Trial.

7

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.

Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. Koskinen P, et al. Among authors: heinonen op. Diabetes Care. 1992 Jul;15(7):820-5. doi: 10.2337/diacare.15.7.820. Diabetes Care. 1992. PMID: 1516498 Clinical Trial.

8

Compliance with medication in the Helsinki Heart Study.

Mäenpää H, Manninen V, Heinonen OP. Mäenpää H, et al. Among authors: heinonen op. Eur J Clin Pharmacol. 1992;42(1):15-9. doi: 10.1007/BF00314913. Eur J Clin Pharmacol. 1992. PMID: 1541311

9

Leukocytes as a coronary risk factor in a dyslipidemic male population.

Mänttäri M, Manninen V, Koskinen P, Huttunen JK, Oksanen E, Tenkanen L, Heinonen OP, Frick MH. Mänttäri M, et al. Among authors: heinonen op. Am Heart J. 1992 Apr;123(4 Pt 1):873-7. doi: 10.1016/0002-8703(92)90690-w. Am Heart J. 1992. PMID: 1549995

10

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH. Manninen V, et al. Among authors: heinonen op. Circulation. 1992 Jan;85(1):37-45. doi: 10.1161/01.cir.85.1.37. Circulation. 1992. PMID: 1728471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page